US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 15, 2015 (11 years ago)

Tobramycin 14 mg/mL Ophthalmic Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

What was recalled

Tobramycin 14 mg/mL Ophthalmic Solution, 15 mL bottle, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.

Recalling firm
Liberty Drug & Surgical
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1389-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tobramycin recalls

See all
Class II · Moderate risk Terminated

Tobramycin for Injection

Reason Failed Stability Specification: Water determination was found not complying with specification.

Eugia US LLC NDC 55150-470-06 D-0385-2024
Class III · Low risk Ongoing

Tobramycin Opthalmic Solution USP

Reason Failed Impurities/Degradation Specifications

Alembic Pharmaceuticals, INC. NDC 62332-518-05 D-1086-2023
Class II · Moderate risk Ongoing

Tobramycin Ophthalmic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0851-2023
Class II · Moderate risk Ongoing

Tobramycin Inhalation Solution USP

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0850-2023
Class II · Moderate risk Terminated

Tobramycin 660mg in Ns 66ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0317-2023